These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30568908)

  • 1. Antibiotic resistance trends of ESKAPE pathogens in Kwazulu-Natal, South Africa: A five-year retrospective analysis.
    Ramsamy Y; Essack SY; Sartorius B; Patel M; Mlisana KP
    Afr J Lab Med; 2018; 7(2):887. PubMed ID: 30568908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Antibiotic Resistance of ESKAPE Pathogens Over Five Years in an Infectious Diseases Hospital from South-East of Romania.
    Arbune M; Gurau G; Niculet E; Iancu AV; Lupasteanu G; Fotea S; Vasile MC; Tatu AL
    Infect Drug Resist; 2021; 14():2369-2378. PubMed ID: 34194233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
    Pandey R; Mishra SK; Shrestha A
    Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa.
    Founou RC; Founou LL; Allam M; Ismail A; Essack SY
    Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Analysis on Antimicrobial Resistance Trends and Prevalence of β-lactamases in
    Nasser M; Palwe S; Bhargava RN; Feuilloley MGJ; Kharat AS
    Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33096921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
    Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
    S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
    Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
    Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESKAPE Pathogens: Antimicrobial Resistance Patterns, Risk Factors, and Outcomes a Retrospective Cross-Sectional Study of Hospitalized Patients in Palestine.
    Abukhalil AD; Barakat SA; Mansour A; Al-Shami N; Naseef H
    Infect Drug Resist; 2024; 17():3813-3823. PubMed ID: 39247758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
    Seifert H; Blondeau J; Dowzicky MJ
    Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and characterization of ESKAPE organisms on the hands of veterinary students before patient contact at a veterinary academic hospital, South Africa.
    Sebola DC; Oguttu JW; Malahlela MN; Kock MM; Qekwana DN
    BMC Vet Res; 2024 Oct; 20(1):475. PubMed ID: 39420336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in resistance pattern of ESKAPE pathogens between 2010 and 2020 in the clinical center of University of Szeged, Hungary.
    Orosz L; Lengyel G; Ánosi N; Lakatos L; Burián K
    Acta Microbiol Immunol Hung; 2022 Jan; ():. PubMed ID: 35084364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital.
    Flores-Paredes W; Luque N; Albornoz R; Rojas N; Espinoza M; Pons MJ; Ruiz J
    Infect Chemother; 2021 Sep; 53(3):449-462. PubMed ID: 34508324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
    De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
    J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018].
    Li SG; Liao K; Su DH; Zhuo C; Chu YZ; Hu ZD; Xu XL; Zhang R; Liu WE; Lu BH; Zeng J; Jin Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3775-3783. PubMed ID: 33379842
    [No Abstract]   [Full Text] [Related]  

  • 19. Extended spectrum beta-lactamase mediated resistance in carriage and clinical gram-negative ESKAPE bacteria: a comparative study between a district and tertiary hospital in South Africa.
    Founou RC; Founou LL; Essack SY
    Antimicrob Resist Infect Control; 2018; 7():134. PubMed ID: 30473784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ESKAPE Pathogens on Bacteremia: A Three-Year Surveillance Study at a Major Hospital in Southern Italy.
    De Prisco M; Manente R; Santella B; Serretiello E; Dell'Annunziata F; Santoro E; Bernardi FF; D'Amore C; Perrella A; Pagliano P; Boccia G; Franci G; Folliero V
    Antibiotics (Basel); 2024 Sep; 13(9):. PubMed ID: 39335074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.